PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
暂无分享,去创建一个
G. Hortobagyi | L. Pusztai | H. Gómez | W. Symmans | V. Valero | A. Bardelli | C. Liedtke | A. Tordai | L. Cardone | E. Souchon | R. Hubbard | Kai Yan | Luis J Barajas Figureoa